Viewing Study NCT02423603

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-02-22 @ 9:39 AM
Study NCT ID: NCT02423603
Status: COMPLETED
Last Update Posted: 2025-03-10
First Post: 2014-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
Sponsor: Queen Mary University of London
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PAKT View
None Capivasertib View
None Triple Negative Breast Cancer View
None Metastatic View
None AKT Inhibitor View
None Advanced View
None AZD5363 View
None Paclitaxel View